Clinical Trial Update: Breast Cancer PET/CT Imaging With 68Ga-pAKTi

View source ↗

Summary

Clinical trial update: PET/CT imaging with the radiotracer 68Ga-pAKTi is enrolling by invitation in breast cancer patients, including those with PIK3CA-mutant a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Pi3k Pathway-activated Tumors
• Pik3ca-mutant Tumors

Drugs mentioned

• 68Ga-pAKTi

Snippet

Sponsor: Fudan University | Conditions: Breast Cancers, PIK3CA Mutation-Related Tumors | Status: ENROLLING_BY_INVITATION